Correction: Adenosine Administration in Young Cardiac Transplant Patients Is Safe and Effective

Correction |
June 13, 2017

Correction: Adenosine Administration in Young Cardiac Transplant Patients Is Safe and Effective

A correction to a summary published June 6, 2017

Due to a misedit, the article Adenosine Administration in Young Cardiac Transplant Patients Is Safe and Effective contained an error in the Comment.

The Comment has been emended to read as follows (correction in italics):

“The current researchers reasonably suggest beginning at 25 mcg/kg in patients <60 kg and 1.5 mg in heavier patients.”

We apologize to our readers.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.